Chirality in new drug development. Clinical pharmacokinetic considerations.
Nation
R L
RL
School of Pharmacy and Medical Science, University of South Australia, Adelaide.
D000375:Aging / Q000378:metabolism; D001711:Biotransformation / Q000235:genetics; D003362:Cost-Benefit Analysis; D004304:Dosage Forms; D004334:Drug Administration Schedule; D015195:Drug Design; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008297:Male; D004364:Pharmaceutical Preparations / Q000737:chemistry* / Q000378:metabolism; D010599:Pharmacokinetics; D012737:Sex Factors; D013237:Stereoisomerism
D004304:Dosage Forms; D004364:Pharmaceutical Preparations